American Journal of Cardiology
Volume 98, Issue 7 , Pages 918-922 , 1 October 2006

Clinical and Angiographic Outcomes After Placement of Multiple Overlapping Drug-Eluting Stents in Diffuse Coronary Lesions

Received 27 January 2006 ,Revised 25 April 2006 ,Accepted 1 May 2006.

References 

  1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization . N Engl J Med . 2002;346:1773–1780
  2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery . N Engl J Med . 2003;349:1315–1323
  3. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions . Circulation . 2003;108:788–794
  4. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, et al. Stented segment length as an independent predictor of restenosis . J Am Coll Cardiol . 1999;34:651–659
  5. Kereiakes D, Linnemeier TJ, Baim DS, Kuntz R, O’Shaughnessy C, Hermiller J, et al. Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials) . Am J Cardiol . 2000;86:336–341
  6. Mauri L, O’Malley AJ, Cutlip DE, Ho KK, Popma JJ, Chauhan MS, et al. Effects of stent length and lesion length on coronary restenosis . Am J Cardiol . 2004;93:1340–1346
  7. Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice . Circulation . 2005;112:3306–3313
  8. Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery . J Am Coll Cardiol . 2005;45:1570–1573
  9. Aoki J, Ong AT, Rodriguez Granillo GA, McFadden EP, van Mieghem CA, Valgimigli M, et al  “Full metal jacket” (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions . Am Heart J . 2005;150:994–999
  10. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial . JAMA . 2005;293:165–171
  11. Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, et al  Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization . N Engl J Med . 2005;353:653–662
  12. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies . J Am Coll Cardiol . 2005;45:954–959
  13. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents . JAMA . 2005;293:2126–2130

 This study was supported by grants from the CardioVascular Research Foundation, Asan Institute for Life Science (Grant 2006-217), and the Korea Health 21 R&D Project, Ministry of Health & Welfare, Korea (Grant 0412-CR02-0704-0001).

PII: S0002-9149(06)01179-9

doi: 10.1016/j.amjcard.2006.05.011

American Journal of Cardiology
Volume 98, Issue 7 , Pages 918-922 , 1 October 2006

Article Tools

* Image Usage & Resolution